These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


151 related items for PubMed ID: 38395605

  • 1. Novel endotypes of antisynthetase syndrome identified independent of anti-aminoacyl transfer RNA synthetase antibody specificity that improve prognostic stratification.
    Wu S, Xiao X, Zhang Y, Zhang X, Wang G, Peng Q.
    Ann Rheum Dis; 2024 May 15; 83(6):775-786. PubMed ID: 38395605
    [Abstract] [Full Text] [Related]

  • 2. Clinical characteristics and prognostic analysis of idiopathic inflammatory myopathy with positive anti-aminoacyl-tRNA synthetase antibodies: A single center experience.
    Zhang D, Wang H, Zhou X, Yang J, Liu Y, Wang W, Jiang P, Fan B.
    Immun Inflamm Dis; 2023 Nov 15; 11(11):e1085. PubMed ID: 38018600
    [Abstract] [Full Text] [Related]

  • 3. Clinical manifestations of skin, lung and muscle diseases in dermatomyositis positive for anti-aminoacyl tRNA synthetase antibodies.
    Fukamatsu H, Hirai Y, Miyake T, Kaji T, Morizane S, Yokoyama E, Hamada T, Oono T, Koyama Y, Norikane S, Iwatsuki K.
    J Dermatol; 2019 Oct 15; 46(10):886-897. PubMed ID: 31418479
    [Abstract] [Full Text] [Related]

  • 4. Hierarchical cluster and survival analyses of antisynthetase syndrome: phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity.
    Hervier B, Devilliers H, Stanciu R, Meyer A, Uzunhan Y, Masseau A, Dubucquoi S, Hatron PY, Musset L, Wallaert B, Nunes H, Maisonobe T, Olsson NO, Adoue D, Arlet P, Sibilia J, Guiguet M, Lauque D, Amoura Z, Hachulla E, Hamidou M, Benveniste O.
    Autoimmun Rev; 2012 Dec 15; 12(2):210-7. PubMed ID: 22771754
    [Abstract] [Full Text] [Related]

  • 5. The long-term outcome of interstitial lung disease with anti-aminoacyl-tRNA synthetase antibodies.
    Tanizawa K, Handa T, Nakashima R, Kubo T, Hosono Y, Watanabe K, Aihara K, Ikezoe K, Sokai A, Nakatsuka Y, Taguchi Y, Hatta K, Noma S, Kobashi Y, Yoshizawa A, Oga T, Hirai T, Chin K, Nagai S, Izumi T, Mimori T, Mishima M.
    Respir Med; 2017 Jun 15; 127():57-64. PubMed ID: 28461123
    [Abstract] [Full Text] [Related]

  • 6. Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease.
    Hozumi H, Fujisawa T, Nakashima R, Johkoh T, Sumikawa H, Murakami A, Enomoto N, Inui N, Nakamura Y, Hosono Y, Imura Y, Mimori T, Suda T.
    Respir Med; 2016 Dec 15; 121():91-99. PubMed ID: 27888997
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome.
    Hamaguchi Y, Fujimoto M, Matsushita T, Kaji K, Komura K, Hasegawa M, Kodera M, Muroi E, Fujikawa K, Seishima M, Yamada H, Yamada R, Sato S, Takehara K, Kuwana M.
    PLoS One; 2013 Dec 15; 8(4):e60442. PubMed ID: 23573256
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Myositis-related interstitial lung disease and antisynthetase syndrome.
    Solomon J, Swigris JJ, Brown KK.
    J Bras Pneumol; 2011 Dec 15; 37(1):100-9. PubMed ID: 21390438
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Clinical heterogeneity and prognostic features of South Australian patients with anti-synthetase autoantibodies.
    Dugar M, Cox S, Limaye V, Blumbergs P, Roberts-Thomson PJ.
    Intern Med J; 2011 Sep 15; 41(9):674-9. PubMed ID: 20059602
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Clinical characteristics of patients with anti-aminoacyl-tRNA synthetase antibody positive idiopathic interstitial pneumonia.
    Yura H, Sakamoto N, Satoh M, Ishimoto H, Hanaka T, Ito C, Hasegawa T, Tanaka S, Miyamura T, Nakashima S, Hara A, Kakugawa T, Oda K, Kido T, Obase Y, Ishimatsu Y, Yatera K, Kawakami A, Mukae H.
    Respir Med; 2017 Nov 15; 132():189-194. PubMed ID: 29229096
    [Abstract] [Full Text] [Related]

  • 19. Heterogeneous clinical spectrum of interstitial lung disease in patients with anti-EJ anti-synthetase syndrome: a case series.
    Giannini M, Notarnicola A, Dastmalchi M, Lundberg IE, Lopalco G, Iannone F.
    Clin Rheumatol; 2016 Sep 15; 35(9):2363-7. PubMed ID: 27068736
    [Abstract] [Full Text] [Related]

  • 20. Clinical features and outcomes of the patients with anti-glycyl tRNA synthetase syndrome.
    Zhang Y, Ge Y, Yang H, Chen H, Tian X, Huang Z, Liu S, Lu X, Wang G.
    Clin Rheumatol; 2020 Aug 15; 39(8):2417-2424. PubMed ID: 32144624
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.